These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24695040)

  • 1. The association between plasminogen activator inhibitor type 1 (PAI-1) levels, PAI-1 4G/5G polymorphism, and myocardial infarction: a Mendelian randomization meta-analysis.
    Nikolopoulos GK; Bagos PG; Tsangaris I; Tsiara CG; Kopterides P; Vaiopoulos A; Kapsimali V; Bonovas S; Tsantes AE
    Clin Chem Lab Med; 2014 Jul; 52(7):937-50. PubMed ID: 24695040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of PAI-1 4G/5G and -844G/A gene polymorphisms and changes in PAI-1/tissue plasminogen activator levels in myocardial infarction: a case-control study.
    Abboud N; Ghazouani L; Saidi S; Ben-Hadj-Khalifa S; Addad F; Almawi WY; Mahjoub T
    Genet Test Mol Biomarkers; 2010 Feb; 14(1):23-7. PubMed ID: 19929406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is not associated with myocardial infarction.
    Doggen CJ; Bertina RM; Cats VM; Reitsma PH; Rosendaal FR
    Thromb Haemost; 1999 Jul; 82(1):115-20. PubMed ID: 10456464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator inhibitor type 1 gene polymorphisms and haplotypes are associated with plasma plasminogen activator inhibitor type 1 levels but not with myocardial infarction or stroke.
    Ding J; Nicklas BJ; Fallin MD; de Rekeneire N; Kritchevsky SB; Pahor M; Rodondi N; Li R; Zmuda JM; Harris TB
    Am Heart J; 2006 Dec; 152(6):1109-15. PubMed ID: 17161063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between gene polymorphism of the PAI-1 promoter and myocardial infarction.
    Fu L; Jin H; Song K; Zhang C; Shen J; Huang Y
    Chin Med J (Engl); 2001 Mar; 114(3):266-9. PubMed ID: 11780311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced carriership of 4G allele of plasminogen activator inhibitor-1 4G/5G polymorphism in very young survivors of myocardial infarction.
    Rallidis LS; Gialeraki A; Merkouri E; Liakos G; Dagres N; Sionis D; Travlou A; Lekakis J; Kremastinos DT
    J Thromb Thrombolysis; 2010 May; 29(4):497-502. PubMed ID: 19844663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of tissue plasminogen activator and plasminogen activator inhibitor polymorphism with myocardial infarction: a meta-analysis.
    Gong LL; Peng JH; Han FF; Zhu J; Fang LH; Wang YH; Du GH; Wang HY; Liu LH
    Thromb Res; 2012 Sep; 130(3):e43-51. PubMed ID: 22771216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study. Etude CasTemoins de I'nfarctus du Mycocarde.
    Ye S; Green FR; Scarabin PY; Nicaud V; Bara L; Dawson SJ; Humphries SE; Evans A; Luc G; Cambou JP
    Thromb Haemost; 1995 Sep; 74(3):837-41. PubMed ID: 8571307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An effect of the PAI-1 4G/5G polymorphism on cholesterol levels may explain conflicting associations with myocardial infarction and stroke.
    Boncoraglio GB; Bodini A; Brambilla C; Carriero MR; Ciusani E; Parati EA
    Cerebrovasc Dis; 2006; 22(2-3):191-5. PubMed ID: 16735791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism, coronary thrombosis, and myocardial infarction in middle-aged Finnish men who died suddenly.
    Mikkelsson J; Perola M; Wartiovaara U; Peltonen L; Palotie A; Penttilä A; Karhunen PJ
    Thromb Haemost; 2000 Jul; 84(1):78-82. PubMed ID: 10928474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of association of a common polymorphism of the plasminogen activator inhibitor-1 gene with coronary artery disease and myocardial infarction.
    Anderson JL; Muhlestein JB; Habashi J; Carlquist JF; Bair TL; Elmer SP; Davis BP
    J Am Coll Cardiol; 1999 Nov; 34(6):1778-83. PubMed ID: 10577569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activator inhibitor-1 4G/5G gene polymorphism in patients with myocardial or cerebrovascular infarction in Tianjin, China.
    Zhan M; Zhou Y; Han Z
    Chin Med J (Engl); 2003 Nov; 116(11):1707-10. PubMed ID: 14642142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAI-1 level and the PAI-1 4G/5G polymorphism in relation to risk of non-fatal myocardial infarction: results from the Stockholm Heart Epidemiology Program (SHEEP).
    Leander K; Wiman B; Hallqvist J; Sten-Linder M; de Faire U;
    Thromb Haemost; 2003 Jun; 89(6):1064-71. PubMed ID: 12783120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of PAI-1 promoter 4G/5G insertion/deletion polymorphism with myocardial infarction and stroke in young women.
    Hindorff LA; Schwartz SM; Siscovick DS; Psaty BM; Longstreth WT; Reiner AP
    J Cardiovasc Risk; 2002 Apr; 9(2):131-7. PubMed ID: 12006921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G genotype and increased PAI-1 circulating levels in postmenopausal women with coronary artery disease.
    Grancha S; Estellés A; Tormo G; Falco C; Gilabert J; España F; Cano A; Segui R; Aznar J
    Thromb Haemost; 1999 Apr; 81(4):516-21. PubMed ID: 10235431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator inhibitor-1 5G/5G genotype is associated with early spontaneous recanalization of the infarct-related artery in patients presenting with acute ST-elevation myocardial infarction.
    Cagliyan CE; Yuregir OO; Balli M; Tekin K; Akilli RE; Bozdogan ST; Turkmen S; Deniz A; Baykan OA; Aslan H; Cayli M
    Coron Artery Dis; 2013 May; 24(3):196-200. PubMed ID: 23283030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 4G/5G polymorphism of the plasminogen activator inhibitor gene is associated with the time course of progression to acute coronary syndromes.
    Iwai N; Shimoike H; Nakamura Y; Tamaki S; Kinoshita M
    Atherosclerosis; 1998 Jan; 136(1):109-14. PubMed ID: 9544737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activator inhibitor-1 promoter 4G/5G genotype and plasma levels in relation to a history of myocardial infarction in patients characterized by coronary angiography.
    Ossei-Gerning N; Mansfield MW; Stickland MH; Wilson IJ; Grant PJ
    Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):33-7. PubMed ID: 9012634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The plasminogen activator inhibitor-1 -675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin and insulin concentrations in men from Europe: the HIFMECH study.
    Juhan-Vague I; Morange PE; Frere C; Aillaud MF; Alessi MC; Hawe E; Boquist S; Tornvall P; Yudkin JS; Tremoli E; Margaglione M; Di Minno G; Hamsten A; Humphries SE;
    J Thromb Haemost; 2003 Nov; 1(11):2322-9. PubMed ID: 14629464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAI-1 Gene 4G/5G polymorphism and risk of type 2 diabetes in a population-based sample.
    Meigs JB; Dupuis J; Liu C; O'Donnell CJ; Fox CS; Kathiresan S; Gabriel SB; Larson MG; Yang Q; Herbert AG; Wilson PW; Feng D; Tofler GH; Cupples LA
    Obesity (Silver Spring); 2006 May; 14(5):753-8. PubMed ID: 16855181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.